NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair and CEO Ron Bentsur bought $54K of Nuvectis Pharma, Inc.
Bought$53,890
$6.34Price
8,500Shares
What NVCT did for a copier
- $1,000 copied at Fri, Feb 11 open, $6.13
- $1,117
- S&P 500, same days
- +1.8%
Measured over 30 trading days, to the Mar 28 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +40.0% against the S&P 500, and 7 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Feb 10. Filed Fri, Feb 11, 4:15 AM ET, before the open. Returns use the Feb 11 open and the Mar 28 close. Not investment advice.